APA

Frankle W. G., Gil R., Hackett E., Mawlawi O., Zea-Ponce Y., Zhu Z., Kochan L. D., Cangiano C., Slifstein M., Gorman J. M., Laruelle M. & Abi-Dargham A. (20050126). Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications. : Psychopharmacology.

Chicago

Frankle W G, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan L D, Cangiano C, Slifstein M, Gorman J M, Laruelle M and Abi-Dargham A. 20050126. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications. : Psychopharmacology.

Harvard

Frankle W. G., Gil R., Hackett E., Mawlawi O., Zea-Ponce Y., Zhu Z., Kochan L. D., Cangiano C., Slifstein M., Gorman J. M., Laruelle M. and Abi-Dargham A. (20050126). Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications. : Psychopharmacology.

MLA

Frankle W G, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan L D, Cangiano C, Slifstein M, Gorman J M, Laruelle M and Abi-Dargham A. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications. : Psychopharmacology. 20050126.